{
  "meta": {
    "title": "61_Sle_Anti_Phospholipid_Syndrome",
    "url": "https://brainandscalpel.vercel.app/61-sle-anti-phospholipid-syndrome-913cdf97.html",
    "scrapedAt": "2025-11-30T18:13:08.703Z"
  },
  "questions": [
    {
      "text": "A 25-year-old woman presents with fatigue, joint pain, and a photosensitive rash. She reports mouth ulcers and hair loss. Laboratory tests show positive ANA and elevated anti-ds DNA antibodies. Further examination reveals elevated levels of IFN-α.\n\nWhich of the following is a consequence of elevated IFN-α in this condition?",
      "choices": [
        {
          "id": 0,
          "text": "Decreased B cell activation"
        },
        {
          "id": 1,
          "text": "Enhanced clearance of apoptotic cells"
        },
        {
          "id": 2,
          "text": "Suppression of T cell activity"
        },
        {
          "id": 3,
          "text": "Increased antibodies production"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<ul>\n\t<li>The clinical presentation of fatigue, joint pain, <span class=\"customMeta\" data-dictid=\"99af5986841692777195c8f611e7f0\">photosensitive</span> rash, mouth ulcers, hair loss, positive <span class=\"customMeta\" data-dictid=\"a0db54ebbf1692777181d7ff70d047\">ANA</span> and anti-dsDNA antibodies suggest <strong>systemic lupus</strong> <strong>erythematosus (SLE). </strong></li>\n\t<li><strong>Elevated levels of IFN-α </strong>play a crucial role in <span class=\"customMeta\" data-dictid=\"d9bf27b09416927771984cdc6c0bc4\">SLE</span> <span class=\"customMeta\" data-dictid=\"715b4caf0316927771943797627d8d\">pathogenesis</span> by <strong>promoting B cell activation</strong> and <strong>increasing <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> production</strong>, particularly autoantibodies such as <strong>anti-dsDNA. </strong></li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:NaN\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Predisposing/Risk factors of SLE</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Genetic factors</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Environmental factors</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Complement deficiencies of <strong>C1q, C2, and C4</strong></li>\n\t\t\t\t<li><strong>TREX1</strong> gene mutations</li>\n\t\t\t\t<li>Affecting <span class=\"customMeta\" data-dictid=\"782b31281a1692777181708484c1d1\">antigen</span> presentation of <strong>HLA-DRB, DR3, DQA2</strong></li>\n\t\t\t\t<li><strong>Enhanced <span class=\"customMeta\" data-dictid=\"cc8345eacd1692777190c2e063a170\">innate</span> immunity</strong>, mainly increased production of IFNs</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Gender: <strong>Female</strong></li>\n\t\t\t\t<li>OCPs and HRT</li>\n\t\t\t\t<li>Ultraviolet light</li>\n\t\t\t\t<li>Smoking</li>\n\t\t\t\t<li>Silicosis</li>\n\t\t\t\t<li>Vitamin D deficiency</li>\n\t\t\t\t<li>EBV infection.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p><strong>Pathogenesis of SLE:</strong></p>\n\n<p> </p>\n\n<p> </p>\n\n<p><strong>Decreased B cell activation (Option A): </strong> IFN-α <strong>promotes</strong> B cell <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> and survival, <strong>not decreases it</strong>. This contributes to <strong>autoantibody production</strong> in SLE.</p>\n\n<p> </p>\n\n<p><strong>Enhanced <span class=\"customMeta\" data-dictid=\"3a3fb1b8a816927771840e6a344cc0\">clearance</span> of apoptotic c</strong>ells (Option B): In SLE, <strong>clearance is defective</strong>, contributing to accumulation of nuclear debris → <strong>triggers autoimmunity.</strong></p>\n\n<p> </p>\n\n<p><strong>Suppression of T cell activity (Option C): </strong>IFN-α <strong>activates <span class=\"customMeta\" data-dictid=\"77f797c5e8169277718535480fa7fd\">dendritic</span> cells</strong> and promotes <strong>T cell activation</strong>, not suppression.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 30-year-old woman presents with a history of recurrent fever, myalgia, photosensitivity, and joint pain. On examination, multiple erythematous plaques with adherent scales are noted on her face and scalp. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 0,
          "text": "Urticarial eruptions"
        },
        {
          "id": 1,
          "text": "Malar rash"
        },
        {
          "id": 2,
          "text": "Subacute cutaneous lupus erythematosus (SCLE)"
        },
        {
          "id": 3,
          "text": "Discoid lupus erythematosus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Option: D) Discoid <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus</strong></p>\n\n<p> </p>\n\n<ul>\n\t<li>The patient's symptoms of <span class=\"customMeta\" data-dictid=\"c64e3a661b1692777197afc2ff7bca\">recurrent</span> fever, myalgia, photosensitivity, and joint pain, along with erythematous plaques with adherent scales on the face and scalp, suggest <strong>Discoid <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Erythematosus (DLE),</strong> a chronic <span class=\"customMeta\" data-dictid=\"94f1c8df1f1692777185bd6a7c3fff\">cutaneous</span> <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> of lupus.</li>\n\t<li>It is characterised by <strong>round, scaly, slightly raised, erythematous plaques with hyperpigmented rims and depigmented centres</strong> that occur due to damage to all the <span class=\"customMeta\" data-dictid=\"532334711316927771865e5309b763\">dermal</span> appendages.</li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:627px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Clinical manifestations of SLE</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Constitutional symptoms</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Fever, fatigue, myalgia, weight loss</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Mucocutaneous symptoms</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Malar rash/ Butterfly rash</strong> is <span class=\"customMeta\" data-dictid=\"99af5986841692777195c8f611e7f0\">photosensitive</span> and involves the cheeks and nose, <strong>sparing the <span class=\"customMeta\" data-dictid=\"0d0dc81f3e1692777193490eadcacd\">nasolabial</span> folds.</strong> <strong>(Option B)</strong></li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Malar rash\" data-author=\"Doktorinternet\" data-hash=\"9901\" data-license=\"CC BY SA 4.0\" data-source=\"https://en.wikipedia.org/wiki/Malar_rash\" data-tags=\"April2025\" height=\"342\" src=\"https://image.prepladder.com/notes/cGNKnkTtHAH5ffzNOvrT1744447670.png\" width=\"342\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<ul>\n\t\t\t\t<li><strong>Discoid <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus</strong></li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Discoid lupus erythematosus\" data-author=\"Mohammad2018 \" data-hash=\"9902\" data-license=\"CC BY SA 4.0\" data-source=\"https://en.wikipedia.org/wiki/Discoid_lupus_erythematosus\" data-tags=\"April2025\" height=\"428\" src=\"https://image.prepladder.com/notes/KD9cPXbIG6uWxZBQ2uov1744447789.png\" width=\"355\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<ul>\n\t\t\t\t<li><strong>Subacute <span class=\"customMeta\" data-dictid=\"94f1c8df1f1692777185bd6a7c3fff\">cutaneous</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus</strong> are scaly, red, <span class=\"customMeta\" data-dictid=\"0919f0017e1692777184ac3748841f\">circular</span> or flat, <span class=\"customMeta\" data-dictid=\"96f5104d6816927771816ac8dfceeb\">annular</span> lesions, similar to <span class=\"customMeta\" data-dictid=\"8b9f55244b1692777196b5ddb9a6bf\">psoriasis</span> <strong>(Option C)</strong></li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Subacute cutaneous lupus erythematosus\" data-author=\"Uva, Luís & Miguel, Diana & Pinheiro, Catarina & Freitas, Joao & Gomes, Manuel & Filipe, Paulo\" data-hash=\"9903\" data-license=\"CC BY 4.0\" data-source=\"https://www.researchgate.net/publication/230659291_Cutaneous_Manifestations_of_Systemic_Lupus_Erythematosus/citation/download\" data-tags=\"April2025\" height=\"284\" src=\"https://image.prepladder.com/notes/W2A8jjvUlE44Te6k2Yr31744447910.png\" width=\"399\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<ul>\n\t\t\t\t<li><strong>Ulcers</strong></li>\n\t\t\t\t<li><strong>Lichen planus</strong></li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Lichen planus\" data-author=\"James Heilman, MD \" data-hash=\"9904\" data-license=\"CC BY SA 3.0\" data-source=\"https://en.wikipedia.org/wiki/Lichen_planus\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/CNcD7l9MPvoZJNSGloEo1744448017.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<ul>\n\t\t\t\t<li><strong>Urticarial eruptions</strong> are red or skin-coloured, raised, and surrounded by a <span class=\"customMeta\" data-dictid=\"95af91681416927771887742113c38\">halo</span> of redness <strong>(Option A)</strong></li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Urticarial eruptions\" data-author=\"James Heilman, MD \" data-hash=\"9905\" data-license=\"CC BY SA 3.0\" data-source=\"https://en.wikipedia.org/wiki/Hives\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/dPyszrz38BkyoyKNrQlz1744448123.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Musculoskeletal symptoms</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Joint pain with <span class=\"customMeta\" data-dictid=\"7d66a14e2416927771993133552ae6\">synovitis</span> involving more than two joints, typically non-erosive but occasionally leading to deformities in severe cases.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anemia </strong></p>\n\t\t\t</td>\n\t\t\t<td rowspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Due to <span class=\"customMeta\" data-dictid=\"96ab11a06a16927771823151c8e471\">autoimmune</span> reactions, it can happen without other organ involvement.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Thrombocytopenia</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Neuropsychiatric involvement </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Cognitive impairment, mood disorders, psychosis, stroke, seizures, <span class=\"customMeta\" data-dictid=\"255674f3271692777195c172d86daf\">peripheral</span> neuropathy, etc.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Lung and <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">Renal</span> involvement</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>This can be seen in 50% of patients affected with SLE.</li>\n\t\t\t\t<li>Pulmonary manifestations may include <strong>pleuritis,</strong> <span class=\"customMeta\" data-dictid=\"f46ba26d111692777190def3b1d80a\">interstitial</span> lung disease, or <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> hypertension.</li>\n\t\t\t\t<li>Renal involvement typically presents as <strong>lupus nephritis, </strong>characterised by proteinuria, hematuria, and, in severe cases, progressive <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> dysfunction.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>",
      "question_images": [
        "https://image.prepladder.com/notes/476zdl7J5Rc56ap8dRcs1744447533.png"
      ],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/notes/cGNKnkTtHAH5ffzNOvrT1744447670.png"
      ],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 26-year-old woman presents with chest pain worsened by deep breathing, shortness of breath, fatigue, joint pain, and a photosensitive facial rash. Physical examination reveals tenderness over the chest wall and mild joint swelling. Laboratory tests show positive ANA and elevated anti-dsDNA antibodies. A chest X-ray shows mild pleural effusion. Which of the following pulmonary complications is most likely associated with her condition?\n\n(ARDS: Acute Respiratory Distress Syndrome)",
      "choices": [
        {
          "id": 0,
          "text": "ARDS"
        },
        {
          "id": 1,
          "text": "Shrinking lung syndrome"
        },
        {
          "id": 2,
          "text": "Pulmonary hypertension"
        },
        {
          "id": 3,
          "text": "Pleuritis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<ul>\n\t<li>The patient's presentation of <span class=\"customMeta\" data-dictid=\"f8034b340e1692777184abcfab32f3\">chest pain</span> that worsens with deep breathing, along with a history of fatigue, joint pain, photosensitivity, and positive <span class=\"customMeta\" data-dictid=\"96ab11a06a16927771823151c8e471\">autoimmune</span> markers (ANA, anti-dsDNA), suggests <strong>Systemic <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Erythematosus (SLE)</strong>.</li>\n\t<li><strong>Pleuritis</strong> is the<strong> most common <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> manifestation </strong>of SLE, and it can present with or without effusion.</li>\n\t<li>It can be managed by <strong>NSAIDs in its mild <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> and with a short course of glucocorticoids in case of severe pleuritis.</strong></li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:654px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Systemic Involvement in SLE</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>System</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Manifestations</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Pulmonary system</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Pleuritis</strong><strong> (most common): </strong>Prevalence (30 - 50%)</li>\n\t\t\t\t<li>Pneumonitis</li>\n\t\t\t\t<li>Atelectasis</li>\n\t\t\t\t<li>Reduced lung volume and</li>\n\t\t\t\t<li>Pulmonary ﬁbrosis</li>\n\t\t\t\t<li>Shrinking lung syndrome, (< 5%) <strong>(Option B ruled out)</strong></li>\n\t\t\t\t<li>Intra-alveolar hemorrhage</li>\n\t\t\t\t<li>Pulmonary HTN (< 5 %)<strong> (Option C ruled out)</strong></li>\n\t\t\t\t<li>Acute <span class=\"customMeta\" data-dictid=\"cfad80a0f716927771979aae100f95\">Respiratory</span> <span class=\"customMeta\" data-dictid=\"afafb9026e1692777186e3dd168fa8\">Distress</span> Syndrome (ARDS) (< 5%) <strong>(Option A ruled out)</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Musculoskeletal system</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>It is the most <strong>commonly involved system</strong></li>\n\t\t\t\t<li>Polyarthritis (<strong>symmetrical)</strong></li>\n\t\t\t\t<li>Polyarthralgia</li>\n\t\t\t\t<li><strong>Rheumatoid arthritis</strong></li>\n\t\t\t\t<li><strong>Myositis</strong></li>\n\t\t\t\t<li><strong>Jaccoud arthropathy</strong> is a <span class=\"customMeta\" data-dictid=\"a4488d66fc16927771975d043c4ccc\">reversible</span> <span class=\"customMeta\" data-dictid=\"ce2b48d83d1692777185427cee6c98\">deformity</span> caused by <span class=\"customMeta\" data-dictid=\"301e3b01f01692777191aced6dc342\">ligament</span> laxity, <span class=\"customMeta\" data-dictid=\"54635b1bf01692777183247ecff5e0\">capsule</span> fibrosis, and <span class=\"customMeta\" data-dictid=\"9e2d8a3f5a16927771932c2348ec52\">muscular</span> imbalance.</li>\n\t\t\t\t<li>Axial skeletal involvement is uncommon.</li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Jaccoud arthropathy\" data-author=\"A. Najm, B. Le Goff, A. Achille, O. Espitia, C. Durant, F. Perrin, C. Agard\" data-hash=\"9906\" data-license=\"\" data-source=\"https://www.semanticscholar.org/paper/%5BThree-cases-of-Jaccoud%27s-arthropathy-during-Najm-Goff/f933e204973a6fe2477e6c41c5b29e3cac6436bd\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/HMwCOgDHhNk3VXZwZEiR1744448299.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<p> </p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Renal system</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Lupus <span class=\"customMeta\" data-dictid=\"d4d4bbdd341692777193b705a75667\">nephritis</span> (most common)</strong></li>\n\t\t\t\t<li>Proteinuria</li>\n\t\t\t\t<li>Nephrotic syndrome</li>\n\t\t\t\t<li>Rarely End-stage <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">Renal</span> Disease (ESRD)</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Nervous system</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Headache, Seizures, Stroke, Polyneuropathy, TIA, <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">Acute</span> confusional state, Movement disorder, <span class=\"customMeta\" data-dictid=\"50ca3536ab16927771820138ef02f8\">Aseptic</span> meningitis, Myelopathy, <span class=\"customMeta\" data-dictid=\"1cb2d1482916927771964c2890313e\">Psychosis</span> and Mood disorders.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Cardiovascular system</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Coronary <span class=\"customMeta\" data-dictid=\"a66cd3adaa1692777182e77cb23021\">artery</span> disease - common <span class=\"customMeta\" data-dictid=\"254dc5106d1692777183ba9ab1b3e5\">cause of death</span> </strong></li>\n\t\t\t\t<li>Pericarditis</li>\n\t\t\t\t<li>Coronary vasculitis</li>\n\t\t\t\t<li>Myocarditis</li>\n\t\t\t\t<li><strong>Libman sacks endocarditis</strong></li>\n\t\t\t\t<li>Accelerated atherosclerosis</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Hematological manifestations</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Anemia of chronic disease</li>\n\t\t\t\t<li>Leucopenia</li>\n\t\t\t\t<li>Lymphopenia</li>\n\t\t\t\t<li>Thrombocytopenia</li>\n\t\t\t\t<li>Autoimmune <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">Hemolytic</span> anemia-MCC of <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> in SLE</li>\n\t\t\t\t<li>Splenomegaly</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>GI involvement</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Abdominal pain</li>\n\t\t\t\t<li>Nausea, diarrhoea</li>\n\t\t\t\t<li>Abnormal liver enzymes</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Ocular manifestation</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Sicca syndrome: <strong>Dry eyes (keratoconjunctivitis sicca) </strong>and<strong> <span class=\"customMeta\" data-dictid=\"e3afd7f63b1692777186b9a6e7824d\">dry mouth</span> (xerostomia).</strong></li>\n\t\t\t\t<li>Conjunctivitis</li>\n\t\t\t\t<li><strong>Episcleritis</strong></li>\n\t\t\t\t<li>Vasculitis</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/notes/HMwCOgDHhNk3VXZwZEiR1744448299.png"
      ],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 28-year-old woman presents with joint pain and skin rashes after being treated with trimethoprim-sulfamethoxazole for a recent infection. She has a history of Systemic lupus erythematosus. Laboratory tests reveal positive anti-dsDNA antibodies. Which of the following antibodies would be more specific for diagnosing the cause of her symptoms?",
      "choices": [
        {
          "id": 0,
          "text": "Anti-Ro"
        },
        {
          "id": 1,
          "text": "Anti-RNP"
        },
        {
          "id": 2,
          "text": "Anti-C1q"
        },
        {
          "id": 3,
          "text": "Antihistone"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Antihistone antibodies </strong>are the most specific antibodies for diagnosing <strong>drug-induced lupus.</strong></p>\n\n<p> </p>\n\n<p><strong>Common drugs associated with drug-induced <span class=\"customMeta\" data-dictid=\"d9bf27b09416927771984cdc6c0bc4\">SLE</span> are (Mnemonic: SHIP)</strong></p>\n\n<ul>\n\t<li><strong>S</strong>ulfa drugs</li>\n</ul>\n\n<ul>\n\t<li><strong>H</strong>ydralazine</li>\n\t<li><strong>I</strong>soniazid</li>\n\t<li><strong>P</strong>rocainamide</li>\n\t<li>Dapsone</li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:656px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"3\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Autoantibodies of SLE</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Antibodies</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Antigen recognised</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Clinical significance</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>ANA</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Multiple nuclear antigens</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Best screening test for diagnosis, it is <strong>highly sensitive but not very specific</strong> for SLE.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anti-dsDNA</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>DNA (double-stranded)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>High titers are specific for SLE</strong></p>\n\n\t\t\t<p>Used to correlate with disease severity</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anti-C1q</strong></p>\n\n\t\t\t<p><strong>(Option C ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Collagen-like determinants on C1q</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with active <strong>lupus nephritis</strong>, it is non-specific for <span class=\"customMeta\" data-dictid=\"d9bf27b09416927771984cdc6c0bc4\">SLE</span> and can be used to <strong>correlate with disease activity. <span class=\"customMeta\" data-dictid=\"209b85faf71692777185767d43e3bd\">Deficiency</span> predisposes SLE.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anti-Sm</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Protein complexed to 6 species of nuclear U1 RNA.</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>It is <strong>highly specific for SLE.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anti-RNP (Option B ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Protein complexed to U1 RNA</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Non-specific to SLE</strong> and is associated with <strong>syndromes that <span class=\"customMeta\" data-dictid=\"ea564f2f5e1692777194df1391fd69\">overlap</span> with rheumatic syndromes</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anti-Ro (SS-A) (Option A ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Protein complexed to hY <span class=\"customMeta\" data-dictid=\"cc65bdc03f169277719726a675e8a7\">RNA</span> 9 (primarily 60 <span class=\"customMeta\" data-dictid=\"027c8b222c16927771909172487af7\">kDa</span> and 52 kDa)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Not very specific</strong>, it is associated with <strong>sicca syndrome and <span class=\"customMeta\" data-dictid=\"77493a5b781692777193df12530299\">neonatal</span> lupus</strong> (congenital heart block)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anti-La (SS-B)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>47-kDa protein complexed to hY RNA</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Commonly associated with <strong>Anti-Ro antibody</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Antihistone</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Histones associated with DNA</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with <strong>drug-induced lupus.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Antiphospholipid</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Phospholipids, β2-glycoprotein 1 cofactor, prothrombin</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Usually predisposes to <strong>clotting, <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> loss and thrombocytopenia.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anti Erythrocyte</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Erythrocyte membrane</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Causes <strong>autoimmune <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">hemolytic</span> anemia.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Antiplatelet</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Surface and altered cytoplasmic antigens on platelets</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>It contributes to <strong>thrombocytopenia,</strong> is<strong> not very specific or sensitive, </strong>and is not used in regular practice.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Antineuronal antibody</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Neuronal and <span class=\"customMeta\" data-dictid=\"c605d4126116927771916c2002638e\">lymphocyte</span> surface antigens</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Occasionally, it shows a positive correlation with <strong>active <span class=\"customMeta\" data-dictid=\"e1a4a12fb416927771841c46faf6fb\">CNS</span> lupus.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anti Ribosomal P</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Protein in ribosomes</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with <strong>neuropsychiatric manifestations.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 27-year-old woman presents with joint pain, fatigue, and a malar rash. Laboratory tests reveal positive ANA and anti-dsDNA antibodies. According to the EULAR/ACR classification criteria, which of the following criteria is not required for diagnosis?",
      "choices": [
        {
          "id": 0,
          "text": "Antiphospholipid antibodies"
        },
        {
          "id": 1,
          "text": "Serositis"
        },
        {
          "id": 2,
          "text": "Neuropsychiatric symptoms"
        },
        {
          "id": 3,
          "text": "Ocular symptoms"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct answer- D) Ocular symptoms</strong></p>\n\n<ul>\n\t<li>Though <strong>GI and <span class=\"customMeta\" data-dictid=\"7b1f175723169277719459db16938e\">ocular</span> symptoms</strong> are part of SLE manifestations, <strong>they aren't</strong> <strong>included in the EULAR/ACR <span class=\"customMeta\" data-dictid=\"dda6ab11271692777184264b752d39\">Classification</span> Criteria</strong> for SLE.</li>\n\t<li>This <span class=\"customMeta\" data-dictid=\"dda6ab11271692777184264b752d39\">classification</span> includes both clinical & <span class=\"customMeta\" data-dictid=\"6eec2212b91692777189b54f3d9066\">immunological</span> criteria; the patient <strong>must fulfil at least one clinical criterion, and ≥10 points are classified.</strong></li>\n\t<li><strong>ANA positive</strong> ( <span class=\"customMeta\" data-dictid=\"07e6f3a1921692777200051f692a60\">titer</span> of ≥ 1:80 on Hep-2 cells) is the required entry criteria to classify SLE.</li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:703px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"4\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>EULAR/ACR <span class=\"customMeta\" data-dictid=\"dda6ab11271692777184264b752d39\">Classification</span> Criteria for SLE</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Clinical Domain and Criteria</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Weight</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Immunological Domain and Criteria</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Weight</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Constitutional</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Fever</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>2</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Antiphospholipid antibodies (Option A ruled out)</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Anti-cardiolipin antibodies or</li>\n\t\t\t\t<li>Anti-b2GP1 antibodies or</li>\n\t\t\t\t<li>Lupus anticoagulant</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>2</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Hematologic</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Leukopenia</li>\n\t\t\t\t<li>Thrombocytopenia</li>\n\t\t\t\t<li>Autoimmune <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">hemolytic</span> anemia</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>3</p>\n\n\t\t\t<p>4</p>\n\n\t\t\t<p>4</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Complement proteins</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Low C3 or low C4</li>\n\t\t\t\t<li>Low C3 and C4</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>3</p>\n\n\t\t\t<p>4</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Neuropsychiatric (Option C ruled out)</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Delirium</li>\n\t\t\t\t<li>Psychosis</li>\n\t\t\t\t<li>Seizure</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>2</p>\n\n\t\t\t<p>3</p>\n\n\t\t\t<p>5</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>SLE – speciﬁc antibodies</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Anti-ds DNA <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> or</li>\n\t\t\t\t<li>Anti-Smith antibody</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>6</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Mucocutaneous</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Non-scarring alopecia</li>\n\t\t\t\t<li>Oral ulcers</li>\n\t\t\t\t<li>Subacute <span class=\"customMeta\" data-dictid=\"94f1c8df1f1692777185bd6a7c3fff\">cutaneous</span> OR <span class=\"customMeta\" data-dictid=\"0af8272baf1692777186883cc728db\">discoid</span> lupus</li>\n\t\t\t\t<li>Acute <span class=\"customMeta\" data-dictid=\"94f1c8df1f1692777185bd6a7c3fff\">cutaneous</span> lupus</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>2</p>\n\n\t\t\t<p>2</p>\n\t\t\t \n\n\t\t\t<p>4</p>\n\n\t\t\t<p>6</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> </td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> </td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Serosal (Option B ruled out)</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Pleural or <span class=\"customMeta\" data-dictid=\"85bd8b2ec816927771958f9ebe3568\">pericardial</span> eﬀusion</li>\n\t\t\t\t<li>Acute pericarditis</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>5</p>\n\n\t\t\t<p>6</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> </td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> </td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Musculoskeletal</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Joint Involvement</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>6</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> </td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> </td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Renal</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Proteinuria >0.5 g/24 h</li>\n\t\t\t\t<li>Renal <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> Class II or V <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> nephritis</li>\n\t\t\t\t<li><strong>Renal <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> Class III or IV <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> nephritis</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> \n\t\t\t<p>4</p>\n\t\t\t \n\n\t\t\t<p>8</p>\n\t\t\t \n\n\t\t\t<p>10</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> </td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\"> </td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"4\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>A</strong><strong> positive ANA test </strong><strong>is required as an </strong><strong>entry criterion.</strong></li>\n\t\t\t\t<li><strong>A diagnosis is made if a total score of </strong><strong>≥10 points</strong><strong> is reached based on clinical and <span class=\"customMeta\" data-dictid=\"6eec2212b91692777189b54f3d9066\">immunological</span> features.</strong></li>\n\t\t\t\t<li><strong>All the criteria should be mainly explained by SLE but not be attributed to other medical conditions or factors.</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 25-year-old woman presents with fatigue, a malar rash, and joint pain. Laboratory tests show positive anti-dsDNA, anti-Smith antibodies, and a positive ANA. She undergoes a renal biopsy that reveals features consistent with lupus nephritis. Based on the SLICC criteria, which of the following statements is true?",
      "choices": [
        {
          "id": 0,
          "text": "Four clinical criteria must be met to confirm SLE"
        },
        {
          "id": 1,
          "text": "Renal biopsy indicating lupus with lupus autoantibodies is sufficient"
        },
        {
          "id": 2,
          "text": "At least 2 clinical criteria with one antibody confirms SLE"
        },
        {
          "id": 3,
          "text": "Presence of Anti-ds, Anti-Sm and ANA confirms SLE"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct answer: B) Renal <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> indicating <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> with <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> autoantibodies is sufficient</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li>The SLICC (Systemic <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> International Collaborating Clinics) criteria state that SLE can be diagnosed if a patient meets 4 criteria, including at least 1 clinical and 1 <span class=\"customMeta\" data-dictid=\"6eec2212b91692777189b54f3d9066\">immunological</span> criterion.</li>\n\t<li>However, SLE can also be diagnosed if a <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> shows<strong> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> nephritis</strong> and the patient has positive <span class=\"customMeta\" data-dictid=\"a0db54ebbf1692777181d7ff70d047\">ANA</span> or anti-dsDNA antibodies, regardless of meeting other clinical or <span class=\"customMeta\" data-dictid=\"6eec2212b91692777189b54f3d9066\">immunological</span> criteria.</li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Systemic <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> International Collaborating Clinic (SLICC) Criteria</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Clinical Manifestations</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Immunological Manifestations</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Skin:</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li><strong>Acute <span class=\"customMeta\" data-dictid=\"94f1c8df1f1692777185bd6a7c3fff\">cutaneous</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus</strong> (photosensitive, malar, maculopapular, bullous)</li>\n\t\t\t\t<li><strong>Chronic <span class=\"customMeta\" data-dictid=\"94f1c8df1f1692777185bd6a7c3fff\">cutaneous</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus</strong> (discoid lupus, panniculitis, <span class=\"customMeta\" data-dictid=\"d176adf87f1692777191722064a021\">lichen</span> planus-like, hypertrophic verrucous, chill blains)</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td rowspan=\"8\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>ANA</strong> > reference negative value</li>\n\t\t\t\t<li><strong>Anti-dsDNA </strong>> reference</li>\n\t\t\t</ul>\n\n\t\t\t<p>(if by ELISA, 2× reference)</p>\n\n\t\t\t<ul>\n\t\t\t\t<li><strong>Anti-Sm</strong></li>\n\t\t\t\t<li><strong>Antiphospholipid antibodies</strong></li>\n\t\t\t\t<li>Lupus anticoagulant</li>\n\t\t\t\t<li>Anticardiolipin</li>\n\t\t\t\t<li>Anti–β2-glycoprotein1</li>\n\t\t\t\t<li><strong>Low <span class=\"customMeta\" data-dictid=\"1ffaec13de169277719828374cfda0\">serum</span> <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> </strong>(C3, C4, or CH50)</li>\n\t\t\t\t<li><strong>Positive direct Coombs test</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Oral or <span class=\"customMeta\" data-dictid=\"31c5d0e75f16927771938d8e2daa4c\">nasal</span> ulcers</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Nonscarring alopecia</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Synovitis </strong>involving<strong> ≥2 joints</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Serositis </strong>(Pleurisy or pericarditis)</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Renal:</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Protein-to-creatinine ratio (Prot/Cr) ≥0.5</li>\n\t\t\t\t<li>RBC casts</li>\n\t\t\t\t<li>Renal <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> indicating <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> <strong>(Wire-loop lesions)</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Neurologic:</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Seizures</li>\n\t\t\t\t<li>Psychosis</li>\n\t\t\t\t<li>Mononeuritis & myelitis</li>\n\t\t\t\t<li>Peripheral/Cranial neuropathies</li>\n\t\t\t\t<li>Acute confusional state</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Hematology:</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li>Hemolytic anemia</li>\n\t\t\t\t<li>Leukopenia (<4000/μL)</li>\n\t\t\t\t<li>Lymphopenia (<1000/μL)</li>\n\t\t\t\t<li>Thrombocytopenia (<100,000/μL)</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p><strong>Classification Criteria: </strong></p>\n\n<ul>\n\t<li><strong>At least 4 criteria must be present</strong>, with <strong>at least 1 from the clinical manifestations</strong> and <strong>1 from the <span class=\"customMeta\" data-dictid=\"fced475d231692777189effb72c5c7\">immunologic</span> manifestations. (Option A, C and D ruled out)</strong></li>\n\t<li><strong>A <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> indicating <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> <span class=\"customMeta\" data-dictid=\"d4d4bbdd341692777193b705a75667\">nephritis</span> qualifies as <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">systemic</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus (SLE) if any <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> autoantibodies are present, even if the total criteria are < 4. (Option B)</strong></li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 32-year-old woman with a known history of systemic lupus erythematosus presents with hypertension and elevated creatinine levels. A renal biopsy reveals glomerular inflammation affecting over 50% of her glomeruli. Based on these findings, which class of lupus nephritis does she fall under?",
      "choices": [
        {
          "id": 0,
          "text": "Class V"
        },
        {
          "id": 1,
          "text": "Class II"
        },
        {
          "id": 2,
          "text": "Class III"
        },
        {
          "id": 3,
          "text": "Class IV"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The patient's <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> shows <span class=\"customMeta\" data-dictid=\"89275101301692777186567d1912a0\">diffuse</span> <span class=\"customMeta\" data-dictid=\"1ad1e71a4a1692777188853097f685\">glomerular</span> <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> involving over 50% of glomeruli, and <span class=\"customMeta\" data-dictid=\"0b338fb71b16927771895a4ee94faa\">immunofluorescence</span> shows<strong> wire-loop lesions</strong> corresponding to<strong> Class IV <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> nephritis.</strong></p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:676px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Classification of <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> nephritis</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Class I: Minimal Mesangial <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis</strong></p>\n\t\t\t<br />\n\t\t\t </td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Normal <span class=\"customMeta\" data-dictid=\"c9bd75ce5f1692777188f7fe800061\">glomeruli</span> by light microscopy.</li>\n\t\t\t\t<li>Mesangial immune deposits detected by immunofluorescence.</li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Class I: Minimal Mesangial <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis\" data-author=\"Anders, Hans-Joachim & Fogo, Agnes.\" data-hash=\"11287\" data-license=\"NA\" data-source=\"https://www.researchgate.net/figure/Minimal-mesangial-lupus-nephritis-ISN-RPS-class-I-a-Glomerulus-without-mesangial-or_fig1_259630750\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/EWO9whgITZL4XuMdXwau1745577694.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<p> </p>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Class I: Minimal Mesangial <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis\" data-author=\"Anders, Hans-Joachim & Fogo, Agnes.\" data-hash=\"11288\" data-license=\"NA\" data-source=\"https://www.researchgate.net/figure/Minimal-mesangial-lupus-nephritis-ISN-RPS-class-I-a-Glomerulus-without-mesangial-or_fig1_259630750\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/7rkoLa8SHNfouymAJhfM1745577708.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Class II: Mesangial Proliferative <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis</strong></p>\n\n\t\t\t<p><strong>(Option B ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Light microscopy</strong>: Mesangial <span class=\"customMeta\" data-dictid=\"38226ff6e41692777189b7d1c80f9d\">hypercellularity</span> (or) <span class=\"customMeta\" data-dictid=\"14958c535b1692777192abd2a85abf\">matrix</span> expansion</li>\n\t\t\t\t<li><strong>Mesangial immune deposits</strong></li>\n\t\t\t\t<li>Subepithelial or <span class=\"customMeta\" data-dictid=\"debc628674169277719936b6424a58\">subendothelial</span> deposits may be present.</li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Class II: Mesangial Proliferative <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> <span class=\"customMeta\" data-dictid=\"d4d4bbdd341692777193b705a75667\">Nephritis</span> \" data-author=\"Elshweikh, Samah & Elkhouly, Radwa & Shaalan, Mohamed & Shorbagy, Safinaz\" data-hash=\"9918\" data-license=\"\" data-source=\"https://www.researchgate.net/figure/Class-II-lupus-nephritis-showing-proliferation-of-mesangial-cells-arrow-H-E-X400_fig1_274257010\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/nlMnET1tF0fHvgdu62MP1744449341.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Class II: Mesangial Proliferative <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis\" data-author=\"Habib, Rumana & Islam, Reezwan & Miah, Md & Islam, Md Rashedul & Rahman, Aminur & Bhowmik, Nirmalendu.\" data-hash=\"9923\" data-license=\"CC BY NC 4.0\" data-source=\"https://www.researchgate.net/figure/Fig-6-Mesangial-proliferative-lupus-nephritis-Class-II-lupus-nephritis_fig5_320308764\" data-tags=\"April2025\" height=\"307\" src=\"https://image.prepladder.com/notes/kMspn6TvRyJeAGbU77uC1744449436.png\" width=\"364\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Class III: <span class=\"customMeta\" data-dictid=\"da6db7b0e21692777203c4075458d3\">Focal</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li><strong>Class III (A):</strong> Active lesions—focal proliferative <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> nephritis.</li>\n\t\t\t\t<li><strong>Class III (C):</strong> Chronic inactive lesions—focal <span class=\"customMeta\" data-dictid=\"0aa16e71201692777198c4c07e2392\">sclerosing</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> nephritis.</li>\n\t\t\t\t<li><strong>Class III (A/C):</strong> Active and chronic lesions</li>\n\t\t\t</ul>\n\n\t\t\t<p><strong>(Option C ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Active or inactive <span class=\"customMeta\" data-dictid=\"d3658e1af116927771887bc5b8a57e\">glomerulonephritis</span> involving <strong>≤50%</strong> of all glomeruli.</li>\n\t\t\t\t<li>Focal <span class=\"customMeta\" data-dictid=\"debc628674169277719936b6424a58\">subendothelial</span> immune deposits and possible mesangial alterations</li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Class III: <span class=\"customMeta\" data-dictid=\"da6db7b0e21692777203c4075458d3\">Focal</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis\" data-author=\"Anders, Hans-Joachim & Fogo, Agnes.\" data-hash=\"9928\" data-license=\"\" data-source=\"https://www.researchgate.net/figure/Focal-lupus-nephritis-ISN-RPS-class-III-a-There-is-endocapillary-proliferation-and-a_fig2_259630750\" data-tags=\"April2025\" height=\"273\" src=\"https://image.prepladder.com/notes/UEEpLvA5NHpNGsLjOStp1744449627.png\" width=\"346\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<p> </p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Class IV: <span class=\"customMeta\" data-dictid=\"89275101301692777186567d1912a0\">Diffuse</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li><strong>Class IV-S:</strong> <span class=\"customMeta\" data-dictid=\"89275101301692777186567d1912a0\">Diffuse</span> <span class=\"customMeta\" data-dictid=\"6c572343621692777198867cf8d853\">segmental</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> <span class=\"customMeta\" data-dictid=\"d4d4bbdd341692777193b705a75667\">nephritis</span> (≥50% of involved <span class=\"customMeta\" data-dictid=\"c9bd75ce5f1692777188f7fe800061\">glomeruli</span> have <span class=\"customMeta\" data-dictid=\"6c572343621692777198867cf8d853\">segmental</span> lesions).</li>\n\t\t\t\t<li><strong>Class IV-G:</strong> <span class=\"customMeta\" data-dictid=\"89275101301692777186567d1912a0\">Diffuse</span> global <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> <span class=\"customMeta\" data-dictid=\"d4d4bbdd341692777193b705a75667\">nephritis</span> (≥50% of involved <span class=\"customMeta\" data-dictid=\"c9bd75ce5f1692777188f7fe800061\">glomeruli</span> have global lesions).</li>\n\t\t\t\t<li><strong>Class IV (A):</strong> Active lesion</li>\n\t\t\t\t<li><strong>Class IV (A/C):</strong> Active and chronic lesion</li>\n\t\t\t\t<li><strong>Class IV (C):</strong> Chronic inactive lesions with scars</li>\n\t\t\t</ul>\n\n\t\t\t<p><strong>(Option D)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Active or inactive <span class=\"customMeta\" data-dictid=\"d3658e1af116927771887bc5b8a57e\">glomerulonephritis</span> involving <strong>≥50%</strong> of all glomeruli.</li>\n\t\t\t\t<li>Diffuse <span class=\"customMeta\" data-dictid=\"debc628674169277719936b6424a58\">subendothelial</span> immune deposits and possible mesangial alterations.</li>\n\t\t\t\t<li><strong>Wire-loop lesions </strong>in <strong>IF</strong></li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Class IV: <span class=\"customMeta\" data-dictid=\"89275101301692777186567d1912a0\">Diffuse</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis\" data-author=\"Nephron\" data-hash=\"9932\" data-license=\"CC BY SA 3.0\" data-source=\"https://en.wikipedia.org/wiki/Lupus_nephritis\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/FfjGDUmHHTPFKGQm2YDp1744449733.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<p style=\"text-align:center\"><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"258\" src=\"https://image.prepladder.com/content/CJ8MYYmIfrhtU6jhderu1740583904.png\" width=\"331\" /></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Class V: Membranous <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis</strong></p>\n\n\t\t\t<p><strong>(Option A ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Global or <span class=\"customMeta\" data-dictid=\"6c572343621692777198867cf8d853\">segmental</span> <span class=\"customMeta\" data-dictid=\"94aff4fd141692777199a78b5ed2eb\">subepithelial</span> immune deposits.</li>\n\t\t\t\t<li>Morphologic sequelae are observable by light microscopy, immunofluorescence, or <span class=\"customMeta\" data-dictid=\"d416281a201692777187899c00aed8\">electron</span> microscopy, with or without mesangial alterations.</li>\n\t\t\t\t<li>It may coexist with class III or IV LN.</li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Class V: Membranous <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis\" data-author=\"Giannico, Giovanna & Fogo, Agnes.\" data-hash=\"9940\" data-license=\"\" data-source=\"https://www.researchgate.net/figure/Membranous-lupus-nephropathy-with-segmental-sclerosis-The-area-of-segmental-sclerosis_fig3_230850562\" data-tags=\"April2025\" height=\"264\" src=\"https://image.prepladder.com/notes/SlyQlXjWBLSL6rzkcWCw1744450109.png\" width=\"348\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Class V: Membranous <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis\" data-author=\"Mark A. Lusco, MD1 ∙ Agnes B. Fogo, MD1 agnes.fogo@vanderbilt.edu ∙ Behzad Najafian, MD2 ∙ Charles E. Alpers, MD\" data-hash=\"11289\" data-license=\"NA\" data-source=\"https://www.researchgate.net/figure/Membranous-lupus-nephropathy-with-segmental-sclerosis-The-area-of-segmental-sclerosis_fig3_230850562\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/vS2K8cCxTgw4CZ3MpXxe1745577733.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Class VI: Advanced <span class=\"customMeta\" data-dictid=\"934e9f88af169277719847f1a0728f\">Sclerotic</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>≥90% </strong>of <span class=\"customMeta\" data-dictid=\"c9bd75ce5f1692777188f7fe800061\">glomeruli</span> globally sclerosed.</li>\n\t\t\t\t<li>No <span class=\"customMeta\" data-dictid=\"a459f313d9169277719789fdfb7ada\">residual</span> activity.</li>\n\t\t\t</ul>\n\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Class VI: Advanced <span class=\"customMeta\" data-dictid=\"934e9f88af169277719847f1a0728f\">Sclerotic</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Nephritis\" data-author=\"Giannico, Giovanna & Fogo, Agnes.\" data-hash=\"9945\" data-license=\"\" data-source=\"https://www.researchgate.net/figure/Global-sclerosis-in-lupus-nephritis-Despite-the-extensive-degree-of-sclerosis-the_fig2_230850562\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/uCmY10nv6PvfQY5Lshrh1744450426.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [
        "https://image.prepladder.com/notes/0fLsf7FioQg4AWVByB7L1744448515.png"
      ],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/CJ8MYYmIfrhtU6jhderu1740583904.png"
      ],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 28-year-old woman with a history of SLE presents with increased fatigue, severe joint pain and pleuritis with features suggestive of coronary artery disease. Laboratory tests indicate elevated serum creatinine. Which of the following management strategies is most appropriate for this patient?",
      "choices": [
        {
          "id": 0,
          "text": "High-dose glucocorticoids and Cyclophosphamide"
        },
        {
          "id": 1,
          "text": "Hydroxychloroquine and NSAIDs for symptom relief"
        },
        {
          "id": 2,
          "text": "Low-dose glucocorticoids, along with azathioprine"
        },
        {
          "id": 3,
          "text": "Conservative management with close monitoring and supportive care"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p>For <span class=\"customMeta\" data-dictid=\"d9bf27b09416927771984cdc6c0bc4\">SLE</span> patients with severe disease presenting with significant organ involvement, the most appropriate management strategy is <strong>high-dose glucocorticoids and cyclophosphamide</strong>.</p>\n\n<p> </p>\n\n<p><strong>Management of <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">Systemic</span> <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">Lupus</span> Erythematosus (SLE):</strong></p>\n\n<p><strong>1. Mild to Moderate Disease:</strong></p>\n\n<ul>\n\t<li>Physical and lifestyle modifications like stress reduction techniques, smoking cessation, <span class=\"customMeta\" data-dictid=\"d9e97c1e031692777195374413d3af\">photoprotection</span> and diet rich in vitamin D.</li>\n\t<li>Analgesics and NSAIDs</li>\n\t<li>Hydroxychloroquine <strong>(Option B)</strong></li>\n\t<li><strong>Glucocorticoids </strong><strong>(Option C)</strong><strong> </strong><strong>(prednisolone 5–20 mg/day) </strong>- often combined with immunosuppressants such as:\n\t<ul>\n\t\t<li>Methotrexate</li>\n\t\t<li>Azathioprine</li>\n\t\t<li>Mycophenolate <span class=\"customMeta\" data-dictid=\"17da2d277916927771924fc9179235\">mofetil</span> (MMF)</li>\n\t</ul>\n\t</li>\n\t<li>Increased <span class=\"customMeta\" data-dictid=\"6045a2ba311692777188aaeacafe4f\">glucocorticoid</span> doses may be needed for <strong>flares</strong> (e.g., pleurisy, pericarditis)</li>\n\t<li><strong>Belimumab</strong> (a <span class=\"customMeta\" data-dictid=\"b2b82438d6169277719287eb450079\">monoclonal</span> <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> BLyS) and <strong>anifrolumab</strong> are effective for persistent disease activity.</li>\n</ul>\n\n<p><strong>2. Severe and Life-Threatening Disease:</strong></p>\n\n<ul>\n\t<li><strong>High-dose glucocorticoids and immunosuppressants </strong>for organ involvement</li>\n\t<li><strong>Common Regimen:</strong>\n\t<ul>\n\t\t<li>Pulsed <span class=\"customMeta\" data-dictid=\"c3adf9f403169277719294351e8fb8\">methylprednisolone</span> IV (10 mg/kg) for 3 days, followed by oral steroid.</li>\n\t\t<li>Cyclophosphamide (15 mg/kg IV), repeated every 2–3 weeks for six cycles.</li>\n\t</ul>\n\t</li>\n\t<li>Patients with significant <span class=\"customMeta\" data-dictid=\"1f58deccf71692777196e64781a01a\">proteinuria</span> (>500 mg daily) should receive<strong> <span class=\"customMeta\" data-dictid=\"677d11eaae169277718087b28f2992\">ACE</span> inhibitors or ARBs </strong>to prevent ESRD.</li>\n\t<li><strong>Safety Considerations:</strong>\n\t<ul>\n\t\t<li>Cyclophosphamide may cause hemorrhagic cystitis; minimise risk with <span class=\"customMeta\" data-dictid=\"a195b609f61692777189953f3adaa6\">hydration</span> and <span class=\"customMeta\" data-dictid=\"86d2f65bdd16927771923625cd22d5\">mesna</span> (2-mercaptoethane sulfonate).</li>\n\t\t<li>Consider <span class=\"customMeta\" data-dictid=\"8dc15ef09e1692777198320917e46b\">sperm</span> or <span class=\"customMeta\" data-dictid=\"c6c40c102d1692777194a23b2674c4\">oocyte</span> collection before treatment due to the risks of <span class=\"customMeta\" data-dictid=\"30e3cd418e16927771829a413730c2\">azoospermia</span> and <span class=\"customMeta\" data-dictid=\"84f13673191692777196762b18e036\">premature</span> menopause.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Alternate Therapy:</strong>\n\t<ul>\n\t\t<li><strong>MMF can be used with high-dose glucocorticoids for <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> involvement</strong>. It shows similar <span class=\"customMeta\" data-dictid=\"7f80be61231692777187391e91e867\">efficacy</span> to <span class=\"customMeta\" data-dictid=\"a6ed2a5f63169277718507c569e576\">cyclophosphamide</span> with fewer side effects.</li>\n\t\t<li>Belimumab and Rituximab.</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>3. Maintenance Therapy: (Post <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">Acute</span> Management)</strong></p>\n\n<ul>\n\t<li>Gradual reduction of oral <span class=\"customMeta\" data-dictid=\"2d5e8899351692777196bdf7ced01d\">prednisolone</span> from 40–60 to 10–15 mg/day within 3 months.</li>\n\t<li>Mycophenolate and <span class=\"customMeta\" data-dictid=\"80fd8ffd0816927771826bfe7129d6\">azathioprine</span> are preferred; both are safer than cyclophosphamide.</li>\n\t<li>Aim for the lowest effective doses, regularly reassessing function and disease activity.</li>\n</ul>\n\n<p> </p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 35-year-old woman with a history of hypertension presents with fever, rash, and joint pain. Laboratory tests show positive ANA and anti-histone antibodies. She has no signs of renal or neurological involvement. Which of the following medications is most likely responsible for her symptoms?",
      "choices": [
        {
          "id": 0,
          "text": "Metoprolol"
        },
        {
          "id": 1,
          "text": "Hydrochlorothiazide"
        },
        {
          "id": 2,
          "text": "Hydralazine"
        },
        {
          "id": 3,
          "text": "Amlodipine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Hydralazine</strong> is a known trigger for drug-induced lupus, especially in patients with a history of hypertension. It is associated with <strong>positive anti-histone antibodies</strong> and symptoms consistent with <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus.</p>\n\n<p> </p>\n\n<p><strong>Drug-Induced Lupus: </strong></p>\n\n<ul>\n\t<li>It is more common in whites and has less female predominance than SLE.</li>\n\t<li>Linked to <strong>Antihistone antibodies </strong>and <strong>not associated with Anti-dsDNA Antibodies</strong></li>\n\t<li>It rarely affects the kidneys or brain; symptoms usually resolve within several weeks after discontinuing the offending medication.</li>\n\t<li><strong>Common offending agents for drug-induced lupus: (Options A,B and D ruled out)</strong>\n\t<ul>\n\t\t<li><strong>Antiarrhythmics:</strong> Procainamide, disopyramide, propafenone</li>\n\t\t<li><strong>Antihypertensives:</strong> <strong>Hydralazine</strong></li>\n\t\t<li><strong>Antithyroid:</strong> Propylthiouracil</li>\n\t\t<li><strong>Antipsychotics:</strong> Chlorpromazine, lithium</li>\n\t\t<li><strong>Anticonvulsants:</strong> Carbamazepine, phenytoin</li>\n\t\t<li><strong>Antibiotics:</strong> Isoniazid, minocycline, nitrofurantoin, dapsone</li>\n\t\t<li><strong>Antirheumatics:</strong> Sulfasalazine</li>\n\t\t<li><strong>Diuretics:</strong> Hydrochlorothiazide</li>\n\t\t<li><strong>Antihyperlipidemic:</strong> Lovastatin, Simvastatin</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p> </p>\n\n<p><strong>Clinical considerations:</strong> In drug-induced lupus, <span class=\"customMeta\" data-dictid=\"a0db54ebbf1692777181d7ff70d047\">ANA</span> typically appears before clinical symptoms. It is important to test for <span class=\"customMeta\" data-dictid=\"a0db54ebbf1692777181d7ff70d047\">ANA</span> at the first indication of relevant symptoms and to consider discontinuing the suspected medication based on test results.</p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 45-year-old man with TB on ATT isoniazid therapy presents with fatigue, fever, joint pain, and a rash. Laboratory tests reveal a positive antinuclear antibody (ANA) test, and anti-histone antibodies are detected. Which of the following ANA staining patterns is most likely found in this patient?",
      "choices": [
        {
          "id": 0,
          "text": "Diffuse"
        },
        {
          "id": 1,
          "text": "Speckled"
        },
        {
          "id": 2,
          "text": "Nucleolar"
        },
        {
          "id": 3,
          "text": "Centromere"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<ul>\n\t<li>The clinical presentation, along with positive anti-histone antibodies, suggests <strong>drug-induced <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> erythematosus</strong> associated with <strong>isoniazid.</strong></li>\n\t<li><strong>Homogeneous (Diffuse) pattern</strong> is the typical <span class=\"customMeta\" data-dictid=\"a0db54ebbf1692777181d7ff70d047\">ANA</span> pattern seen in Drug-induced lupus, which corresponds with<strong> anti-histone antibodies.</strong></li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:647px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"3\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>ANA patterns of SLE</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>ANA pattern</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Antibody identifies</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Clinical significance</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Diffuse pattern</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Histones</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Significant for<strong> drug-induced lupus</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Peripheral (rim) pattern</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Anti-ds-DNA</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Highly specific for <span class=\"customMeta\" data-dictid=\"d9bf27b09416927771984cdc6c0bc4\">SLE</span> but not very sensitive</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td rowspan=\"6\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Speckled pattern </strong><strong>(Option B ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Anti U1-RNP</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with mixed <span class=\"customMeta\" data-dictid=\"67e237a57c16927771859803f93ab3\">connective</span> tissue disease (MCTD)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Anti Sm</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Is <strong>specific for Lupus</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Anti Ro (SS-A)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with <strong>Sjögren’s, SCLE & <span class=\"customMeta\" data-dictid=\"77493a5b781692777193df12530299\">neonatal</span> lupus.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Anti La (SS-B)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with <strong>Anti-Ro</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Anti Scl-70</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with <strong>diffuse scleroderma</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Anti Jo-1</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with <strong>polymyositis with <span class=\"customMeta\" data-dictid=\"5a679034841692777196d988b49eb5\">pneumonitis</span> and arthritis</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Nucleolar pattern</strong></p>\n\n\t\t\t<p><strong>(Option C ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>RNA polymerase</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with <strong>progressive <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">systemic</span> sclerosis</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Centromere</strong></p>\n\n\t\t\t<p><strong>(Option D ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Kinetochore</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Associated with <strong>CREST, Sjogren’s & thyroiditis</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"3\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<div style=\"text-align:center\">\n\t\t\t<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"ANA patterns of SLE\" data-author=\"Al-Mughales JA\" data-hash=\"9959\" data-license=\"CC BY 4.0\" data-source=\"https://en.wikipedia.org/wiki/Antinuclear_antibody\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/ClevrhavcjhtbxhMiihC1744450955.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n\t\t\t</figure>\n\t\t\t</div>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/notes/ClevrhavcjhtbxhMiihC1744450955.png"
      ],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 35-year-old woman with a history of recurrent miscarriages and recent episodes of deep vein thrombosis is found to have elevated anti-β2-glycoprotein I antibodies. Which of the following pathophysiological mechanisms is primarily responsible for her condition?",
      "choices": [
        {
          "id": 0,
          "text": "Deactivation of the complement pathway"
        },
        {
          "id": 1,
          "text": "Increased apoptosis of endothelial cells"
        },
        {
          "id": 2,
          "text": "Decreased platelet activation"
        },
        {
          "id": 3,
          "text": "Impaired fibrinolysis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<ul>\n\t<li>The clinical scenario of a woman with <span class=\"customMeta\" data-dictid=\"c64e3a661b1692777197afc2ff7bca\">recurrent</span> miscarriages and <span class=\"customMeta\" data-dictid=\"712bb2d2b716927771867d5505033c\">deep <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">vein</span> thrombosis</span> (DVT), along with elevated anti-β2-glycoprotein I antibodies, suggests <strong>antiphospholipid syndrome (APS). </strong></li>\n\t<li>In APS, <strong>increased endothelial cell apoptosis</strong> exposes negatively charged phospholipids, promoting the formation of antiphospholipid antibodies.</li>\n</ul>\n\n<p> </p>\n\n<p><strong>Antiphospholipid Syndrome (APS)</strong> is an <span class=\"customMeta\" data-dictid=\"0f0b2969921692777180de24f0b0c0\">acquired</span> <span class=\"customMeta\" data-dictid=\"70158d6a8316927772008b29ca8100\">thrombophilia</span> mediated by autoantibodies, characterised by <span class=\"customMeta\" data-dictid=\"c64e3a661b1692777197afc2ff7bca\">recurrent</span> arterial or <span class=\"customMeta\" data-dictid=\"96e7e3fecc16927772018cb9f8c8cd\">venous</span> <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">thrombosis</span> and/or pregnancy-related complications. It predominantly affects females and can occur as:</p>\n\n<ul>\n\t<li><strong>Primary APS</strong>: Occurs independently.</li>\n\t<li><strong>Secondary APS</strong>: Associated mainly with <span class=\"customMeta\" data-dictid=\"d9bf27b09416927771984cdc6c0bc4\">SLE</span> and other <span class=\"customMeta\" data-dictid=\"96ab11a06a16927771823151c8e471\">autoimmune</span> diseases.</li>\n</ul>\n\n<p> </p>\n\n<p><strong>Target of Antibodies: </strong>The primary autoantibodies in <span class=\"customMeta\" data-dictid=\"a939aaf63116927771812d73bcb057\">APS</span> target negatively charged phospholipids (PLs) and PL-binding proteins, such as <strong>β2-glycoprotein I (β2GPI)</strong> and <strong>prothrombin.</strong> Antibodies may also target:</p>\n\n<ul>\n\t<li><strong>Lupus Anticoagulant</strong></li>\n\t<li><strong>Cardiolipin</strong></li>\n\t<li><strong>Phosphatidylserine</strong></li>\n\t<li><strong>Protein C</strong></li>\n</ul>\n\n<p> </p>\n\n<p><strong>Pathogenesis: </strong></p>\n\n<ul>\n\t<li>It is <span class=\"customMeta\" data-dictid=\"3978e9614f1692777200abbe4cfa34\">triggered</span> by infections, <span class=\"customMeta\" data-dictid=\"60d563fe241692777194203742bf5b\">oxidative</span> stress, and significant physical stressors (surgery or trauma) in genetically predisposed individuals, resulting in <strong>increased <span class=\"customMeta\" data-dictid=\"4bfa3e6f2c1692777181c53b124cf7\">apoptosis</span> of</strong> <strong>endothelial cells and the</strong> exposure of negatively charged phospholipids (PL).</li>\n\t<li>Exposed PLs bind to <span class=\"customMeta\" data-dictid=\"1ffaec13de169277719828374cfda0\">serum</span> proteins such as<strong> β2-glycoprotein I (β2GPI)</strong> and <strong>prothrombin</strong>, forming <strong>neo-antigens</strong>. The immune system produces antibodies against these neo-antigens, leading to anti-PL antibodies.</li>\n\t<li>The binding of anti-PL antibodies to disrupted endothelial cells initiates coagulation, resulting in <span class=\"customMeta\" data-dictid=\"56c933e0d41692777200b713c46640\">thrombus</span> formation.</li>\n</ul>\n\n<p> </p>\n\n<p style=\"text-align:center\"><img alt=\"Pathogenesis of anti-phospholipid syndrome\" data-author=\"\" data-hash=\"11291\" data-license=\"\" data-source=\"\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/RbDKDDtdowpCXyQrOqcu1745577963.png\" /></p>\n\n<p><strong>Clinical Manifestations:</strong></p>\n\n<ul>\n\t<li><strong>Venous Thrombosis:</strong>\n\n\t<ul>\n\t\t<li><strong>Deep <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">Vein</span> <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">Thrombosis</span> (DVT)</strong> (39%)</li>\n\t\t<li>Pulmonary Embolism</li>\n\t\t<li>Superficial Thrombophlebitis</li>\n\t</ul>\n\t</li>\n\t<li><strong>Arterial Thrombosis:</strong>\n\t<ul>\n\t\t<li><strong>Stroke </strong>(20%)</li>\n\t\t<li>Transient Ischemic Attack (TIA) and Myocardial Ischemia</li>\n\t</ul>\n\t</li>\n\t<li><strong>Obstetric Complications:</strong>\n\t<ul>\n\t\t<li><strong>Recurrent first-trimester abortions (≥3).</strong></li>\n\t\t<li>Unexplained death of a morphologically normal <span class=\"customMeta\" data-dictid=\"421fecf0e21692777202704942ac48\">fetus</span> after 10 weeks.</li>\n\t\t<li>Severe early pre-eclampsia.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Hematologic findings: Thrombocytopenia</strong> and <span class=\"customMeta\" data-dictid=\"96ab11a06a16927771823151c8e471\">Autoimmune</span> <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">Hemolytic</span> Anemia</li>\n\t<li><strong>Livedo Reticularis</strong>: A mottled, lace-like purplish skin discolouration, often occurring with <span class=\"customMeta\" data-dictid=\"526ede3fee169277720184378acc5e\">vascular</span> lesions and <span class=\"customMeta\" data-dictid=\"50ca3536ab16927771820138ef02f8\">aseptic</span> bone necrosis.</li>\n\t<li><strong>Libman-Sacks endocarditis</strong>: Characterized by small vegetations with organised platelet-fibrin microthrombi.</li>\n\t<li><strong>Renal involvement</strong>: May present as hypertension, elevated <span class=\"customMeta\" data-dictid=\"1ffaec13de169277719828374cfda0\">serum</span> creatinine, and proteinuria, with associated thrombotic microangiopathy.</li>\n</ul>\n\n<p> </p>\n\n<p><strong>Deactivation of the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> <span class=\"customMeta\" data-dictid=\"3aa5abc2fa169277719488e088076d\">pathway</span> </strong><strong>(Option A):</strong><strong> </strong>APS is primarily associated with antiphospholipid antibodies that <span class=\"customMeta\" data-dictid=\"dddc752e1716927771807f985bb8bb\">activate</span> the <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> <span class=\"customMeta\" data-dictid=\"6826aa04ef16927771833336e53730\">cascade</span> rather than deactivate the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> pathway.</p>\n\n<p> </p>\n\n<p><strong>Impaired <span class=\"customMeta\" data-dictid=\"efd9265c421692777202931bbcc4be\">fibrinolysis</span> </strong><strong>(Option C)</strong><strong>: </strong>APS is mainly characterised by increased <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> and <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> rather than a failure to break down clots.</p>\n\n<p> </p>\n\n<p><strong>Decreased <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> </strong><strong>(Option D)</strong><strong>: </strong>In APS, the presence of antiphospholipid antibodies leads to increased <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> activation, contributing to <span class=\"customMeta\" data-dictid=\"56c933e0d41692777200b713c46640\">thrombus</span> formation.</p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/notes/RbDKDDtdowpCXyQrOqcu1745577963.png"
      ],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 30-year-old woman presents with a history of recurrent miscarriages, having experienced three miscarriages before 10 weeks of gestation and an unprovoked deep vein thrombosis (DVT) in her left leg six months ago, which required anticoagulation therapy. She is diagnosed with antiphospholipid syndrome. Which of the following is not a diagnostic criterion of antiphospholipid syndrome?",
      "choices": [
        {
          "id": 0,
          "text": "Vascular thrombosis of artery, vein or any small vessel"
        },
        {
          "id": 1,
          "text": "3 or more unexplained consecutive miscarriages before 10 weeks of gestation"
        },
        {
          "id": 2,
          "text": "Positive titer for APLA antibodies on a single occasion"
        },
        {
          "id": 3,
          "text": "One or more unexplained deaths of a normal fetus at or after 10 weeks"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Laboratory criteria for diagnosing Antiphospholipid <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> syndrome (APLA) include the presence of a positive <span class=\"customMeta\" data-dictid=\"07e6f3a1921692777200051f692a60\">titer</span> for APLA antibodies on <strong>two occasions 12 weeks apart.</strong></p>\n\n<p>APLA antibodies include</p>\n\n<ul>\n\t<li><strong>Lupus <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> </strong></li>\n\t<li><strong>Anticardiolipin </strong></li>\n\t<li><strong>Anti-beta-2-glycoprotein-I</strong></li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Diagnosis of antiphospholipid syndrome </strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Clinical criteria </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Vascular <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">thrombosis</span> - one or more clinical episodes of arterial, <span class=\"customMeta\" data-dictid=\"96e7e3fecc16927772018cb9f8c8cd\">venous</span> or small vessel thrombosis<strong> (Option A ruled out)</strong></li>\n\t\t\t\t<li>Pregnancy <span class=\"customMeta\" data-dictid=\"9b7604d5461692777192546af7cabd\">morbidity</span> (anyone)\n\t\t\t\t<ul>\n\t\t\t\t\t<li>One or more unexplained deaths of a normal <span class=\"customMeta\" data-dictid=\"421fecf0e21692777202704942ac48\">fetus</span> at or after 10 weeks of <span class=\"customMeta\" data-dictid=\"55b88ac71d169277718832be1a82c7\">gestation</span> <strong> (Option D ruled out)</strong></li>\n\t\t\t\t\t<li>One or more <span class=\"customMeta\" data-dictid=\"84f13673191692777196762b18e036\">premature</span> births of a normal <span class=\"customMeta\" data-dictid=\"d7bb0026fe169277719321db7b41a2\">neonate</span> before 34 weeks of <span class=\"customMeta\" data-dictid=\"55b88ac71d169277718832be1a82c7\">gestation</span> due to <strong>eclampsia</strong>, <strong>severe pre-eclampsia or <span class=\"customMeta\" data-dictid=\"797686400a16927771956b27d401ff\">placental</span> <span class=\"customMeta\" data-dictid=\"80feaae4b31692777190ea1ba3fc25\">insufficiency</span> </strong></li>\n\t\t\t\t\t<li>Three or more unexplained consecutive miscarriages before 10 weeks of <span class=\"customMeta\" data-dictid=\"55b88ac71d169277718832be1a82c7\">gestation</span> <strong> (Option B ruled out)</strong></li>\n\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Lab criteria </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Intermediate or high <span class=\"customMeta\" data-dictid=\"07e6f3a1921692777200051f692a60\">titer</span> of any one of the following antibodies on <strong>two occasions 12 weeks apart. </strong><strong>(Option C)</strong></p>\n\n\t\t\t<ul>\n\t\t\t\t<li><strong>Lupus <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> </strong></li>\n\t\t\t\t<li><strong>Anticardiolipin </strong></li>\n\t\t\t\t<li><strong>Anti-beta-2-glycoprotein-I</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Diagnosis of APLA: One clinical</strong> + <strong>one laboratory criterion</strong> in the <strong>absence of other thrombophilia</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 32-year-old woman with a known history of antiphospholipid syndrome (APS) was admitted to the hospital due to arterial thrombosis. She had a history of deep vein thrombosis (DVT) one year ago, for which she was treated with warfarin. She has been adherent to her warfarin therapy, with a target INR of 2.5. Investigations show the following reports.\n\nINR: 2.1\n\nLupus antibody: Positive\n\nAnticardiolipin antibody: Positive\n\nAnti-β2 glycoprotein I antibodies: Positive\n\nWhat would be the most appropriate adjustment to her treatment after this arterial thrombosis episode?",
      "choices": [
        {
          "id": 0,
          "text": "Administration of oral hydroxychloroquine"
        },
        {
          "id": 1,
          "text": "Increase the dose of warfarin with a target INR of 3.0 to 4.0"
        },
        {
          "id": 2,
          "text": "Switch to direct oral thrombin inhibitor"
        },
        {
          "id": 3,
          "text": "Switch to low-dose aspirin with prophylactic dose low molecular weight heparin."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Since this patient has experienced arterial thrombosis, the target INR should be raised from the standard range of 2.0-3.0 to 3.0-4.0. This adjustment can be achieved by <strong>increasing the <span class=\"customMeta\" data-dictid=\"b5bd69c9791692777186a40f45ffb6\">dosage</span> of warfarin.</strong></p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:677px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Treatment of antiphospholipid syndrome </strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>After the first <span class=\"customMeta\" data-dictid=\"96e7e3fecc16927772018cb9f8c8cd\">venous</span> thrombosis</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Warfarin - </strong>Lifelong with a target INR 2.0-3.0</li>\n\t\t\t\t<li>Consider <strong>Direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitors</strong> if there is a <span class=\"customMeta\" data-dictid=\"c9f33964851692777185b94f619862\">contraindication</span> to <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">warfarin</span> or failure to achieve target INR *</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Arterial <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">thrombosis</span> </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Increase <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">warfarin</span> dose</strong> with target INR 3.0-4.0 or <strong>(Option B)</strong></li>\n\t\t\t\t<li>Maintain INR 2.0-3.0 and <strong>low-dose <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">aspirin</span> (LDA) </strong>70-100 mg/day</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Pregnant woman with APLA</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>LDA</strong> + <strong>Prophylactic</strong> dose of LMWH <strong>(Option D ruled out)</strong></li>\n\t\t\t\t<li>If <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">thrombosis</span> occurs - <strong>LDA</strong> + <strong>therapeutic</strong> dose of LMWH</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Recurrent obstetric complications, even after standard treatment </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>LDA</strong> + <strong>therapeutic</strong> dose of LMWH</li>\n\t\t\t\t<li><strong>Oral hydroxychloroquine </strong>400 mg / day <strong>(Option A ruled out)</strong></li>\n\t\t\t\t<li><strong>IV <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> </strong>400 mg/kg for 5 days</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Asymptomatic patients with high-risk antiphospholipid profile </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Prophylactic low-dose <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">aspirin</span> </strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Catastrophic antiphospholipid syndrome (CAPS)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Combination therapy </strong>\n\t\t\t\t<ul>\n\t\t\t\t\t<li>Glucocorticoid</li>\n\t\t\t\t\t<li>Heparin</li>\n\t\t\t\t\t<li>Plasmapheresis or IV immunoglobulin</li>\n\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Refractory CAPS</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>B-cell <span class=\"customMeta\" data-dictid=\"7061e0e0051692777186ba9c5f27df\">depletion</span> therapy with <span class=\"customMeta\" data-dictid=\"e3802f488416927771979c6d76c756\">rituximab</span> </strong></li>\n\t\t\t\t<li><strong>Complement <span class=\"customMeta\" data-dictid=\"f03ca2d2a716927771901227bc175a\">inhibition</span> with <span class=\"customMeta\" data-dictid=\"6a9b33e69916927771861bd0e99af4\">Eculizumab</span> </strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>* Avoid direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitors</strong> in cases of prior arterial <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">thrombosis</span> or triple positive APLA <strong>(Option C ruled out)</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following assay tests cannot detect lupus anticoagulant antibodies?",
      "choices": [
        {
          "id": 0,
          "text": "Enzyme-linked immunosorbent assay"
        },
        {
          "id": 1,
          "text": "Activated thromboplastin time"
        },
        {
          "id": 2,
          "text": "Kaolin clotting time"
        },
        {
          "id": 3,
          "text": "Dilute Russell viper venom test"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p>The enzyme-linked <span class=\"customMeta\" data-dictid=\"9660c7ea2116927771894b30a0f80b\">immunosorbent</span> <span class=\"customMeta\" data-dictid=\"fc026ff6d81692777182835f6de6df\">assay</span> cannot detect <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> anticoagulants; instead, it detects anticardiolipin antibodies(gives false positive RPR for syphilis) and Anti-beta-2-glycoprotein-I, which aids in the diagnosis of antiphospholipid syndrome.</p>\n\n<p> </p>\n\n<p><strong>Tests for detecting <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> anticoagulant:</strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:623px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Test</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Principle</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Interpretation</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Dilute <span class=\"customMeta\" data-dictid=\"da8b539b8c1692777197325b19717c\">Russell <span class=\"customMeta\" data-dictid=\"efbb05601b1692777202641ca3e610\">Viper</span> <span class=\"customMeta\" data-dictid=\"ce053080da169277720142dbefddb2\">Venom</span> Time</span> (DRVVT) Test</strong></p>\n\n\t\t\t<p><strong>(Option D ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Utilises <span class=\"customMeta\" data-dictid=\"e63a499e5716927771860681cef17d\">dilute</span> Russell <span class=\"customMeta\" data-dictid=\"efbb05601b1692777202641ca3e610\">viper</span> <span class=\"customMeta\" data-dictid=\"ce053080da169277720142dbefddb2\">venom</span> to <span class=\"customMeta\" data-dictid=\"dddc752e1716927771807f985bb8bb\">activate</span> <span class=\"customMeta\" data-dictid=\"69e0db00bd169277720233cd39735b\">factor X</span> in the <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> cascade.</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Presence of <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> <strong>inhibits <span class=\"customMeta\" data-dictid=\"69e0db00bd169277720233cd39735b\">factor X</span> activation</strong>, leading to prolonged <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> time (no <span class=\"customMeta\" data-dictid=\"5e0b40993316927771844dbf382689\">clot</span> formation).</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Kaolin <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">Clotting</span> Time</strong></p>\n\n\t\t\t<p><strong>(Option C ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Measures the time taken for a <span class=\"customMeta\" data-dictid=\"5e0b40993316927771844dbf382689\">clot</span> to <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> in the presence of kaolin, an <span class=\"customMeta\" data-dictid=\"a095f733351692777180a29940c98a\">activator</span> of the <span class=\"customMeta\" data-dictid=\"a6795c876e169277719057a1099465\">intrinsic</span> pathway.</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Increased <span class=\"customMeta\" data-dictid=\"9a504443b51692777190b7d2b2de65\">kaolin</span> <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> time</strong> indicates the presence of <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> anticoagulant, impairing normal coagulation.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Activated <span class=\"customMeta\" data-dictid=\"40141499f716927771945a13f86369\">Partial <span class=\"customMeta\" data-dictid=\"9b51982d06169277720063c9420fbb\">Thromboplastin</span> Time</span> (aPTT)</strong></p>\n\n\t\t\t<p><strong>(Option B ruled out)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Assesses the <span class=\"customMeta\" data-dictid=\"a6795c876e169277719057a1099465\">intrinsic</span> and common pathways of <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> by measuring the <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> time after adding an <span class=\"customMeta\" data-dictid=\"a095f733351692777180a29940c98a\">activator</span> to plasma.</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Prolonged aPTT</strong> suggests the presence of <span class=\"customMeta\" data-dictid=\"ccd536a9071692777191f53538ca30\">lupus</span> anticoagulant, as it binds to β2-glycoprotein I or <span class=\"customMeta\" data-dictid=\"94b02f097916927771962072dbeeac\">prothrombin</span> and interferes with clotting.</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    }
  ]
}